IMPORTANT SEC AND BLUE SKY DISCLOSURES

The information contained on this website, including the Investor Relations section, is provided for informational purposes only and does not constitute an offer to sell, or the solicitation of an offer to buy any securities in any jurisdiction, including the United States, the European Union, or Australia. Any securities offering or solicitation will be made solely by means of a duly authorized offering memorandum or prospectus, and in compliance with applicable securities laws. 

 The Investor Relations section may contain forward-looking statements within the meaning of applicable securities laws. These statements  may address the company’s strategies, objectives, financial performance, and growth prospects, and are based on current expectations, estimates, and projections. These forward-looking statements are subject to significant risks and uncertainties. Actual results may differ materially from those expressed or implied. The company undertakes no obligation to update or revise any forward-looking statements, except as required by law. Readers are cautioned not to place undue reliance on such statements.

 Neither the United States Securities and Exchange Commission, nor the securities regulators of any state or of any country, including those in the European Union or Australia, have passed upon the adequacy or accuracy of the information presented on this website or in the Investor Relations section. Any representation to the contrary is unlawful. Investment in the company’s securities carries significant risks, including the possible loss of the entire amount invested.

 The information on this website, including information provided in the Investor Relations section, is not intended for persons located in jurisdictions where the distribution or use of such information would be contrary to local laws or regulations. Persons accessing this website are solely responsible for informing themselves of, and complying with, all such restrictions.

 For further information or investor inquiries, please contact our Investor Relations department at investors@medlab.group.